NASDAQ
GRAY

Graybug Vision Inc

Biotechnology & Medical Research
Healthcare

Prices are adjusted according to historical splits.

Graybug Vision Inc Stock Price

Vitals

Today's Low:
$2.81
Today's High:
$2.95
Open Price:
$2.81
52W Low:
$0.4511
52W High:
$10.6246
Prev. Close:
$3
Volume:
13397

Company Statistics

Market Cap.:
$120.98 million
Book Value:
1.658
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-38.18%
Return on Equity TTM:
-70.51%

Company Profile

Graybug Vision Inc had its IPO on 2020-09-25 under the ticker symbol GRAY.

The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Graybug Vision Inc has a staff strength of 8 employees.

Stock update

Shares of Graybug Vision Inc opened at $2.81 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.81 - $2.95, and closed at $2.95.

This is a -1.67% slip from the previous day's closing price.

A total volume of 13,397 shares were traded at the close of the day’s session.

In the last one week, shares of Graybug Vision Inc have increased by +9.26%.

Graybug Vision Inc's Key Ratios

Graybug Vision Inc has a market cap of $120.98 million, indicating a price to book ratio of 0.2956 and a price to sales ratio of 0.

In the last 12-months Graybug Vision Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-32879000. The EBITDA ratio measures Graybug Vision Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Graybug Vision Inc’s operating margin was 0% while its return on assets stood at -38.18% with a return of equity of -70.51%.

In Q1, Graybug Vision Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Graybug Vision Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-20.63 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Graybug Vision Inc’s profitability.

Graybug Vision Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.9057. Its price to sales ratio in the trailing 12-months stood at 0.

Graybug Vision Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$34.67 million
Total Liabilities
$12.65 million
Operating Cash Flow
$4.75 million
Capital Expenditure
$0
Dividend Payout Ratio
0%

Graybug Vision Inc ended 2024 with $34.67 million in total assets and $0 in total liabilities. Its intangible assets were valued at $34.67 million while shareholder equity stood at $22.02 million.

Graybug Vision Inc ended 2024 with $0 in deferred long-term liabilities, $12.65 million in other current liabilities, 1000.00 in common stock, $-130995000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $24.39 million and cash and short-term investments were $34.16 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Graybug Vision Inc’s total current assets stands at $34.50 million while long-term investments were $0 and short-term investments were $9.78 million. Its net receivables were $0 compared to accounts payable of $2.06 million and inventory worth $0.

In 2024, Graybug Vision Inc's operating cash flow was $4.75 million while its capital expenditure stood at $0.

Comparatively, Graybug Vision Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.95
52-Week High
$10.6246
52-Week Low
$0.4511
Analyst Target Price
$3.5

Graybug Vision Inc stock is currently trading at $2.95 per share. It touched a 52-week high of $10.6246 and a 52-week low of $10.6246. Analysts tracking the stock have a 12-month average target price of $3.5.

Its 50-day moving average was $4.07 and 200-day moving average was $3.6 The short ratio stood at 0.91 indicating a short percent outstanding of 0%.

Around 258.5% of the company’s stock are held by insiders while 5452% are held by institutions.

Frequently Asked Questions About Graybug Vision Inc

The stock symbol (also called stock or share ticker) of Graybug Vision Inc is GRAY

The IPO of Graybug Vision Inc took place on 2020-09-25

Similar Industry Stocks (Biotechnology & Medical Research)

Last Price
Chg
Chg%
Mene Inc (MENEF)
$0.29
-0.03
-10.66%
$35.89
-1.88
-4.98%
$60.63
-3.98
-6.16%
$23.79
0
0%
$0.94
0.09
+10.2%
$0.56
0.02
+3.7%
$724.55
-47.2
-6.12%
$2.86
0.01
+0.35%
$4.14
0.01
+0.24%
$42.32
-1.68
-3.82%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company’s lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

Address

203 Redwood Shores Parkway, Redwood City, CA, United States, 94065